Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · IEX Real-Time Price · USD
52.57
+0.42 (0.81%)
At close: Apr 18, 2024, 4:00 PM
55.10
+2.53 (4.81%)
After-hours: Apr 18, 2024, 5:05 PM EDT
Company Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia.
Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Establishment Labs Holdings Inc.
| Country | Costa Rica |
| Founded | 2004 |
| IPO Date | Jul 19, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 908 |
| CEO | Roberto de Mezerville |
Contact Details
Address: Building B15 And 25 Coyol Free Zone Alajuela, G2 20101 Costa Rica | |
| Phone | 50624342400 |
| Website | establishmentlabs.com |
Stock Details
| Ticker Symbol | ESTA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001688757 |
| CUSIP Number | G31249108 |
| ISIN Number | VGG312491084 |
| Employer ID | 98-1436377 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Juan Jose Chacon Quiros | Founder, Chief Executive Officer and Executive Director |
| Rajbir Singh Denhoy | Chief Financial Officer |
| S. Ross Mansbach | General Counsel and Chief Compliance Officer |
| Roberto de Mezerville | Chief Technology Officer |
| Salvador Santos Dada | Head of Special Projects |
| Rosalyn Cole d'Incelli | SVice President of Global Clinical, Medical and US Regulatory Affairs |
| Elizabeth Panzica Newman | Vice President and Head of U.S Business Unit |
| Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
| Neeta Toprani | Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 12, 2024 | ARS | Filing |
| Apr 12, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 12, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 2, 2024 | 8-K | Current Report |
| Mar 5, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 4, 2024 | 10-K | Annual Report |
| Mar 1, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 22, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |